Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
deal
Fierce Biotech
China biotechs ‘reshaping’ US biopharma: Jefferies report
In 2025's Q1, 32% of outlicensing biotech deal value occurred in China versus 21% reported in both 2024 and 2023, according to Jefferies.
Gabrielle Masson
Jul 14, 2025 2:30pm
Ratio inks deal to build radiopharma production facility in Utah
May 13, 2025 10:07am
England's Abcam weighs its options, which could include a sale
Jun 29, 2023 8:05am
Sanofi is offloading 17 meds from its pain and CNS rosters
Jul 12, 2022 9:13am
Collaboration in biopharma is 'alive and well,' panel says
Jan 19, 2022 11:15am
Novartis launches $15B share buyback campaign
Dec 16, 2021 10:20am
